Not applicableStudy completedNCT00889980What this trial is testingMelanoma Molecular Profiling AnalysisWho this might be right forMelanoma University of Pittsburgh 237
Early research (Phase 1)Ended earlyNCT03809624What this trial is testingStudy of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck CancerWho this might be right forMetastatic Solid TumorsNon-small Cell Lung CancerMelanoma+6 more Inhibrx Biosciences, Inc 160
Testing effectiveness (Phase 2)Ended earlyNCT01814046What this trial is testingImmunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular MelanomaWho this might be right forMetastatic Ocular MelanomaMetastatic Uveal Melanoma National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Looking for participantsNCT04787042What this trial is testingPhase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067Who this might be right forCancerSolid TumorMelanoma+6 more Simcha IL-18, Inc. 316
Very early researchStudy completedNCT01666353What this trial is testingPET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade TherapyWho this might be right forMelanomaRenal Cell Carcinoma (RCC)Non-small Cell Lung Cancer (NSCLC) Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Early research (Phase 1)Study completedNCT05479812What this trial is testingDose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid TumorsWho this might be right forMetastatic Solid TumorAdvanced Solid Tumor Werewolf Therapeutics, Inc. 156
Testing effectiveness (Phase 2)UnknownNCT04951583What this trial is testingFecal Microbial Transplantation Non-Small Cell Lung Cancer and MelanomaWho this might be right forNon Small Cell Lung Cancer MetastaticAdvanced Melanoma Centre hospitalier de l'Université de Montréal (CHUM) 45
Large-scale testing (Phase 3)Study completedNCT00472459What this trial is testingPhotodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin CancerWho this might be right forActinic KeratosisWartsBasal Cell Carcinoma+2 more Galderma R&D 82
Testing effectiveness (Phase 2)Looking for participantsNCT05592626What this trial is testingA Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more Marengo Therapeutics, Inc. 366
Not applicableUnknownNCT05402059What this trial is testingClinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical PracticeWho this might be right forMelanomaMelanoma (Skin)Melanoma, Uveal+5 more MelanomaPRO, Russia 1,570
Early research (Phase 1)Study completedNCT03329950What this trial is testingCDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesWho this might be right forMelanomaNon-small Cell Lung CancerBreast Cancer+23 more Celldex Therapeutics 132
Testing effectiveness (Phase 2)Study completedNCT00940225What this trial is testingStudy of Cabozantinib (XL184) in Adults With Advanced MalignanciesWho this might be right forSolid TumorsCancer Exelixis 730
Testing effectiveness (Phase 2)Active Not RecruitingNCT05585320What this trial is testingA Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorPancreatic AdenocarcinomaMalignant Melanoma (Cutaneous)+1 more Immuneering Corporation 209
Not applicableUnknownNCT04842279What this trial is testingFACE-Q in Facial Reconstructive Surgery: A Prospective DatabaseWho this might be right forSkin Cancer, Basal Cell Skin Cancer Skin Cancer, Non-Melanoma Skin Cancers - Squamous Cell Carcinoma Patient Satisfaction McMaster University 300
Testing effectiveness (Phase 2)Study completedNCT02304458What this trial is testingNivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or SarcomasWho this might be right forMetastatic MelanomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorRecurrent Hodgkin Lymphoma+20 more National Cancer Institute (NCI) 140
Early research (Phase 1)Study completedNCT01727076What this trial is testingRecombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck CancerWho this might be right forHead and Neck Squamous Cell CarcinomaRecurrent Head and Neck CarcinomaRecurrent Non-Small Cell Lung Carcinoma+11 more National Cancer Institute (NCI) 20
Very early researchEnded earlyNCT03454243What this trial is testingOral Immunomodulatory Tyrosine Kinase Inhibitor in Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic Solid Tumors Hoffmann-La Roche 1
Early research (Phase 1)Ended earlyNCT01045915What this trial is testingSafety and Efficacy Study of Electrotransfer of Plasmid AMEP to Treat Advanced or Metastatic MelanomaWho this might be right forMelanoma Valerio Therapeutics 5
Early research (Phase 1)Study completedNCT03689192What this trial is testingArginase-1 Peptide Vaccine in Patients With Metastatic Solid TumorsWho this might be right forNon Small Cell Lung CancerUrothelial CarcinomaMalignant Melanoma+5 more Herlev Hospital 13
Early research (Phase 1)Looking for participantsNCT05492682What this trial is testingSTART: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of CancerWho this might be right forMelanoma (Skin)Triple-Negative Breast CancerNon-Small Cell Lung Cancer+5 more Valo Therapeutics Oy 15